Long-term follow-up of children with chronic myeloid leukemia after hematopoietic stem cell transplantation and tyrosine kinase inhibitor therapy
Larisa Brogile(Northwestern University), Sonali Chaudhury(Northwestern University), Morris Kletzel(Lurie Children's Hospital), Jennifer Schneiderman(Northwestern University), Nobuko Hijiya(Lurie Children's Hospital), Irene Helenowski(Northwestern University), Reggie Duerst(Lurie Children's Hospital), Elaine Morgan(Northwestern University), William Tse(Lurie Children's Hospital), Kimberley Dilley(Northwestern University)
Cited by 4
Related Papers
Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure
|Blood|2016|333
Cumulative Incidence of Secondary Neoplasms as a First Event After Childhood Acute Lymphoblastic Leukemia
|JAMA|2007|314
Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients
|Transplantation and Cellular Therapy|2013|248
Ancestry and pharmacogenetics of antileukemic drug toxicity
|Blood|2007|207